A study comparing serum TREM2 levels in coronary artery disease patients with healthy controls suggests that higher soluble TREM2 levels can be used as a biomarker for plaque rupture and predictor of cardiovascular death (Cuciuc et al., 2022). The gene discussed is TREM2; the disease is coronary artery disorder.